Table 4.

Summary of the Outcomes of Randomized Controlled Trials Since 1980 Comparing Endoscopic Sphincterotomy (ES), Open Surgical Common Duct Exploration (Surg.), Laparoscopic Common Bile Duct Exploration (Lap.), and Laparo–ES Rendezvous (Lap.–ES).

Years Intervention Patients n Stone Clearance n (%)* Additional CBDI needed (ES or Surg.) n (%) Complications n (%) Mortality n (%) Length of Hospital Stay d (range)
1980–2000 ES 472 301/358 (84.1) 70/472 (14.8) 73/472 (15.5) 10/472 (2.1) 3.5–17
Surg. 313 201/220 (91.4) 37/265 (14.0) 60/313 (19.2) 4/313 (1.3) 6–22
Lap. 173 130/149 (87.2) 29/149 (19.5) 28/173 (16.2) 1/173 (0.6) 1–6

2001–2010 ES 421 274/353 (77.6) 42/421 (9.8) 55/421 (13.1) 1/421 (0.2) 3–9
Lap. 293 217/239 (90.8) 26/293 (8.9) 31/293 (10.6) 1/293 (0.3) 4–8
Lap.–ES 165 123/131 (93.9) 9/165 (5.5) 8/165 (4.8) 0/165 (0) 3–5

2011–2023 ES 637 496/553 (89.7) 28/433 (6.5) 62/596 (10.4) 3/637 (0.5) 3–11
Lap. 528 423/449 (94.2) 22/366 (6.0) 42/528 (8.0) 0/528 (0) 2–7
Lap.–ES 220 155/167 (92.8) 3/79 (3.8) 8/178 (4.5) 1/220 (0.5) 1–7
* The denominators include the total number of patients entered into the trial, after excluding those with suspected but absent CBD stones.
† The denominators include the number of patients with available data.

CBDI, common bile duct interventions; d, day(s).

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2024 April; 15(2): e0007. ISSN: 2076-9172
Published online 2024 April 28. doi: 10.5041/RMMJ.10521